Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 22387451

Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant low-grade serous carcinoma of the ovary, peritoneum, or fallopian tube.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Gynecol Oncol
Publication date
2012 Jun
First author
Noguera IR

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Noguera IR
      type
      Author
    2. name
      Sun CC
      type
      Author
    3. name
      Broaddus RR
      type
      Author
    4. name
      Branham D
      type
      Author
    5. name
      Levenback CF
      type
      Author
    6. name
      Ramirez PT
      type
      Author
    7. name
      Sood AK
      type
      Author
    8. name
      Coleman RL
      type
      Author
    9. name
      Gershenson DM
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Noguera IR
      type
      Author
    2. name
      Sun CC
      type
      Author
    3. name
      Broaddus RR
      type
      Author
    4. name
      Branham D
      type
      Author
    5. name
      Levenback CF
      type
      Author
    6. name
      Ramirez PT
      type
      Author
    7. name
      Sood AK
      type
      Author
    8. name
      Coleman RL
      type
      Author
    9. name
      Gershenson DM
      type
      Author
    bibliography ids
    1. nci-bib-50ff8d676036211f26a31817
    book metadata
    content sha256
    29ca7e008fdd3831d59fc565241c6c68e1cf0ee600c1a76082069683a8efb1ca
    document type
    citation
    dois
    1. 10.1016/j.ygyno.2012.02.034
    electronic publication date
    display
    2012 Feb 28
    precision
    day
    year
    2012
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:22387451
    immutable id
    pubmed:22387451@29ca7e008fdd3831d59fc565241c6c68e1cf0ee600c1a76082069683a8efb1ca
    journal
    abbreviation
    Gynecol Oncol
    issn electronic
    1095-6859
    issn print
    0090-8258
    issue
    3
    name
    Gynecologic oncology
    nlm unique id
    0365304
    pages
    640-5
    volume
    125
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      22387451
      provenance
      batch id
      b6284687e167e7da9556
      provider
      NCBI PubMed ESummary
      record sha256
      c94bac5061262ec49613a4ab41b6432464530fa63ae8ae67862dca8f5220918c
      response sha256
      64d5b7bb63f574c559af2523b779a262267cbc8e8cd02a5b47f4193cc95cabd3
      retrieved at
      2026-09-09T23:46:45.216259+00:00
      publication date
      display
      2012 Jun
      precision
      month
      year
      2012
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/22387451/
      title
      Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant low-grade serous carcinoma of the ovary, peritoneum, or fallopian tube.

      Preserved source evidence · Not medical advice